Loading organizations...
Loading organizations...

Asymmetry Ventures: seed-stage venture capital firm investing in transformative deep tech startups like biotech, AI, quantum, and space.
Key people at Asymmetry Ventures.
Asymmetry Ventures is a seed-stage venture capital firm based in San Francisco, California, that provides equity financing to early-stage deep technology startups. The firm primarily targets emerging companies operating within the biotechnology, artificial intelligence drug discovery, quantum computing, advanced materials, and space technology sectors. Operating with a traditional venture capital model, the firm typically deploys initial check sizes ranging from $100,000 to $500,000, with the capacity to invest up to $25 million per portfolio company. The organization maintains an active investment pace, completing at least seven new equity transactions throughout 2025 while building a broader portfolio of approximately twenty core investments. The firm's active portfolio features notable deep technology companies such as Atomic Alchemy, Orbit Fab, BillionToOne, Coreshell, and CytoReason. Asymmetry Ventures was officially founded in 2018 by managing partner and sole founder Rob Ness.
Asymmetry Ventures is a leading early-stage venture capital firm based in San Francisco, dedicated to backing startups with the potential to create civilization-level impact. Their mission centers on identifying and supporting technically complex, defensible businesses—those with strong intellectual property, natural barriers to entry, and scalable solutions to major global challenges. The firm’s investment philosophy emphasizes backing visionary founders who are building transformative companies in deep tech, artificial intelligence, biotechnology, aerospace, and sustainability. With over 280 investments, Asymmetry has played a pivotal role in shaping the next generation of innovation, helping startups achieve market dominance and long-term resilience.
Founded by Rob Ness, a former AngelList syndicate lead with over seven years of experience and a track record of deploying $40M+ into early-stage ventures, Asymmetry Ventures emerged from a deep conviction that the most impactful startups are those rooted in science and technology with the potential to redefine industries. Ness’s early investments in unicorns like Foresight Mental Health and BillionToOne laid the foundation for the firm’s reputation as a forward-thinking, founder-first investor. Since its inception, Asymmetry has evolved its focus to prioritize deep tech and “sci-fi”-flavored startups—companies pushing the boundaries of what’s possible in fields ranging from AI to space infrastructure.
Asymmetry Ventures is riding the wave of a global shift toward deep tech and mission-driven entrepreneurship. As industries from healthcare to aerospace face unprecedented disruption, the firm’s focus on defensible, scalable startups positions it at the forefront of technological transformation. The rise of AI, climate tech, and space infrastructure has created fertile ground for Asymmetry’s investment thesis, and its emphasis on “civilization-level impact” aligns with growing investor and societal demand for solutions to existential challenges. By supporting founders who are building the future, Asymmetry is helping to shape the next era of innovation and economic growth.
Asymmetry Ventures is poised to remain a key player in the early-stage ecosystem, especially as deep tech and sustainability continue to attract capital and attention. The firm’s ability to identify and back defensible, high-impact startups will likely become even more valuable as competition for breakthrough innovation intensifies. Looking ahead, Asymmetry’s influence may expand beyond its current sectors, potentially shaping new frontiers in quantum computing, synthetic biology, and space exploration. As the world grapples with complex challenges, Asymmetry’s commitment to backing companies that “push humanity forward” ensures its relevance and impact for years to come.
Key people at Asymmetry Ventures.